Compare Stocks

Enter up to five stock symbols separated by a comma or space (ex. BAC,WFC,JPM,LON:BARC).

Date Range:

	Cellular Biomedicine Group	Harpoon Therapeutics	Prevail Therapeutics	Cabaletta Bio	CASI Pharmaceuticals
Symbol	NASDAQ:CBMG	NASDAQ:HARP	NASDAQ:PRVL	NASDAQ:CABA	NASDAQ:CASI
Price Information
Current Price	$18.24	$21.70	$23.00	$14.22	$3.39
52 Week Range	Hold	Buy	Hold	Buy	Buy
MarketRank™
Overall Score	0.6	1.5	1.4	1.5	1.5
Analysis Score	1.0	3.5	2.2	3.5	3.5
Community Score	2.2	2.3	2.1	2.5	2.5
Dividend Score	0.0	0.0	0.0	0.0	0.0
Ownership Score	0.0	1.7	2.5	1.7	0.8
Earnings & Valuation Score	0.0	0.0	0.0	0.0	0.6
Analyst Ratings
Consensus Recommendation	Hold	Buy	Hold	Buy	Buy
Consensus Price Target	$19.00	$31.50	$23.57	$20.33	$4.25
% Upside from Price Target	4.17% upside	45.16% upside	2.48% upside	42.99% upside	25.37% upside
Trade Information
Market Cap	$355.28 million	$550.75 million	$787.66 million	$342.06 million	$420.17 million
Beta	1.35	0.87	1.59	1.67	0.41
Average Volume	26,651	418,746	953,388	120,093	512,329
Sales & Book Value
Annual Revenue	$340,000.00	$5.78 million	N/A	N/A	$4.13 million
Price / Sales	1,044.94	95.28	N/A	N/A	101.74
Cashflow	N/A	N/A	N/A	N/A	N/A
Price / Cash	N/A	N/A	N/A	N/A	N/A
Book Value	$2.89 per share	$3.82 per share	$4.85 per share	$5.76 per share	$0.76 per share
Price / Book	6.31	5.68	N/A	N/A	4.46
Profitability
Net Income	$-49,980,000.00	$-55,570,000.00	$-63,190,000.00	$-16,940,000.00	$-46,030,000.00
EPS	N/A	($2.55)	($2.22)	($4.07)	($0.42)
Trailing P/E Ratio	N/A	N/A	N/A	N/A	N/A
Forward P/E Ratio	∞	N/A	N/A	N/A	N/A
P/E Growth	N/A	N/A	N/A	N/A	N/A
Net Margins	N/A	-434.74%	N/A	N/A	-402.87%
Return on Equity (ROE)	-144.80%	-68.32%	-55.57%	-22.99%	-60.96%
Return on Assets (ROA)	-61.68%	-29.45%	-48.14%	-22.38%	-42.48%
Dividend
Annual Payout	N/A	N/A	N/A	N/A	N/A
Dividend Yield	N/A	N/A	N/A	N/A	N/A
Three-Year Dividend Growth	N/A	N/A	N/A	N/A	N/A
Payout Ratio	N/A	N/A	N/A	N/A	N/A
Years of Consecutive Dividend Growth	N/A	N/A	N/A	N/A	N/A
Debt
Debt-to-Equity Ratio	N/A	N/A	N/A	N/A	N/A
Current Ratio	0.47%	3.49%	7.56%	27.95%	14.99%
Quick Ratio	0.47%	3.49%	7.56%	27.95%	14.86%
Ownership Information
Institutional Ownership Percentage	21.98%	79.03%	86.80%	68.00%	31.95%
Insider Ownership Percentage	8.50%	34.90%	57.20%	6.51%	24.75%
Miscellaneous
Employees	217	77	66	31	125
Shares Outstanding	19.48 million	25.38 million	34.25 million	24.06 million	123.94 million
Next Earnings Date	2/26/2021 (Estimated)	3/11/2021 (Estimated)	3/25/2021 (Estimated)	3/29/2021 (Estimated)	3/15/2021 (Estimated)
Optionable	Optionable	Not Optionable	Not Optionable	Not Optionable	Not Optionable

Comparison Ideas:

30 Days of MarketBeat All Access for $1.00

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your Risk-Free Trial Subscription Here

Your Ultimate Investing Toolkit

Just $1.00 for your first month.

Compare Stocks

30 Days of MarketBeat All Access for $1.00

Options Trading from Scratch

Market Data and Calendars

Investing Education and Resources